# Study of Leptin for the Treatment of Hypothalamic Amenorrhea

> **NCT00130117** · PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Amenorrhea

## Interventions

- **DRUG:** r-metHuLeptin
- **DRUG:** Oral Contraceptive Pills (OCPs)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00130117
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-08
- **Final completion:** 2016-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00130117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00130117, "Study of Leptin for the Treatment of Hypothalamic Amenorrhea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00130117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*